Analysis Life Sciences Thank You Workshop addresses oncology dose optimization across full span of development
Agency IQ
FEBRUARY 23, 2024
Additionally, this approach is generally no longer applicable to new treatments that are more targeted in their effects, such as immunotherapies and targeted small molecule therapies. This workshop built on three prior workshops held by the FDA-AACR, which took place in 2015, 2016 and 2017.
40 
Let's personalize your content